Clinical Outcomes of Rivaroxaban Monotherapy in Heart Failure Patients With Atrial Fibrillation and Stable Coronary Disease: Insights From the AFIRE Trial.
Yoshiyuki YazakiMasato NakamuraRaisuke IijimaSatoshi YasudaKoichi KaikitaMasaharu AkaoJunya AkoTetsuya MatobaKatsumi MiyauchiNobuhisa HagiwaraKazuo KimuraAtsushi HirayamaKunihiko MatsuiHisao Ogawanull nullPublished in: Circulation (2021)